Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)
Public ClinicalTrials.gov record NCT00807053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Randomized, Placebo-controlled, Parallel Group, Multicenter, Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to demonstrate the efficacy of ciclesonide HFA, applied as a nasal aerosol once daily, in patients with SAR. The secondary objectives are to evaluate Quality-of-Life and safety.
Study identification
- NCT ID
- NCT00807053
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 480 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2007 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jul 2007 (Actual)
- Last update posted
- Dec 5, 2016
2007
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altana/Nycomed | Mission Viejo | California | 92691 | — |
| Altana/Nycomed | Orange | California | 92868 | — |
| Altana/Nycomed | San Diego | California | 92123 | — |
| Altana/Nycomed | Colorado Springs | Colorado | 80907 | — |
| Altana/Nycomed | Denver | Colorado | 80230 | — |
| Altana/Nycomed | Gainsville | Georgia | 30501 | — |
| Altana/Nycomed | Savannah | Georgia | 31406 | — |
| Altana/Nycomed | Stockbridge | Georgia | 30281 | — |
| Altana/Nycomed | Indianapolis | Indiana | 46208 | — |
| Altana/Nycomed | Overland Park | Kansas | 66210 | — |
| Altana/Nycomed | Bethesda | Maryland | 20814 | — |
| Altana/Nycomed | Minneapolis | Minnesota | 55402 | — |
| Altana/Nycomed | St Louis | Missouri | 63141 | — |
| Altana/Nycomed | Lincoln | Nebraska | 68505 | — |
| Altana/Nycomed | Papillion | Nebraska | 68046 | — |
| Altana/Nycomed | Skillman | New Jersey | 08558 | — |
| Altana/Nycomed | West Brick | New Jersey | 08724 | — |
| Altana/Nycomed | Raleigh | North Carolina | 27607 | — |
| Altana/Nycomed | Ashland | Oregon | 97520 | — |
| Altana/Nycomed | Medford | Oregon | 97504 | — |
| Altana/Nycomed | Portland | Oregon | 97213 | — |
| Altana/Nycomed | Blue Bell | Pennsylvania | 19422 | — |
| Altana/Nycomed | Pittsburgh | Pennsylvania | 15241 | — |
| Altana/Nycomed | Upland | Pennsylvania | 19013 | — |
| Altana/Nycomed | Charleston | South Carolina | 29414 | — |
| Altana/Nycomed | Austin | Texas | 78750 | — |
| Altana/Nycomed | New Braunfels | Texas | 78130 | — |
| Altana/Nycomed | San Antonio | Texas | 78229 | — |
| Altana/Nycomed | Draper | Utah | 84020 | — |
| Altana/Nycomed | Burke | Virginia | 22015 | — |
| Altana/Nycomed | Richmond | Virginia | 23226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00807053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2016 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00807053 live on ClinicalTrials.gov.